Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-16 · accession 0001628280-25-013513 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-16 | CPIX | Hamm John M. | VP CFO | F - Tax | $5.46 | -5,930 | 20.1K | -23% | -$32.4K |
| D | 2025-03-18 | 2025-03-17 | CPIX | Hamm John M. | VP CFO | A - Grant | $5.17 | +2,750 | 15.2K | +22% | +$14.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-16 | F | D | 5,930 | $5.46 | 20,073 | D | — | — | (F1) This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. |
| 2 | Derivative | Options (right to buy) | 2025-03-17 | A | A | 2,750 | $5.17 | 15,250 | D | $5.17 · 2029-03-17 to 2035-03-17 | 2,750 Common Stock |